Medindia

X

Sun Pharma Gets Green Signal from FDA for Wellbutrin

by Rajshri on  April 8, 2010 at 9:52 PM Drug News   - G J E 4
 Sun Pharma Gets Green Signal from FDA for Wellbutrin
Indian drugmaker Sun Pharmaceuticals has announced that it has got approval from the U.S. regulatory authorities to market a generic version of GlaxoSmithKline's Wellbutrin SR extended release tablets.
Advertisement

The company, which is in trouble in Israel, said that the FDA approved its application to market a generic version of Wellbutrin on Thursday.

Advertisement
Wellbutrin is an antidepressant medication and works in the brain to treat major depressive disorder and seasonal affective disorder


Source: Medindia
RAS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: